RICHARD F. POPS

Insider Reports History

Location
Dublin 4, Ireland
Signature
/s/ Shantale Greenson, attorney-in-fact for Richard F. Pops
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by RICHARD F. POPS:

Company Role Class Num Shares Value Price $ Report Date Ownership
Alkermes plc. Director and CEO, Alkermes plc, Director Ordinary Shares 1,377,740 $46,223,176 $33.55 05 Feb 2026 Direct
NEUROCRINE BIOSCIENCES INC Director Common Stock 34,480 $3,646,604 $105.76 22 May 2025 Direct
NEUROCRINE BIOSCIENCES INC Director Restricted Stock Unit 2,869 $407,116 $141.90 22 May 2024 Direct
Alkermes plc. Director and CEO, Alkermes plc, Director Employee Stock Option (Right to Buy) 293,921 19 Feb 2025 Direct
NEUROCRINE BIOSCIENCES INC Director Restricted Stock Unit 0 22 May 2025 Direct

Insider Reports Filed by RICHARD F. POPS

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALKS Alkermes plc. 05 Feb 2026 2 -$2,087,816 4 Director and CEO, Alkermes plc, Director 06 Feb 2026, 19:14
NBIX NEUROCRINE BIOSCIENCES INC 21 May 2025 3 $0 4 Director 22 May 2025, 17:23
ALKS Alkermes plc. 19 Feb 2025 1 $0 4 Director and CEO, Alkermes plc, Director 20 Feb 2025, 17:11
ALKS Alkermes plc. 06 Feb 2025 2 -$2,508,846 4 Director and CEO, Alkermes plc, Director 07 Feb 2025, 20:36
NBIX NEUROCRINE BIOSCIENCES INC 22 May 2024 1 $0 4 Director 23 May 2024, 18:26
NBIX NEUROCRINE BIOSCIENCES INC 17 May 2024 3 -$297,860 4 Director 21 May 2024, 17:27
NBIX NEUROCRINE BIOSCIENCES INC 13 Mar 2024 3 -$3,255,621 4 Director 15 Mar 2024, 17:19
NBIX NEUROCRINE BIOSCIENCES INC 08 Mar 2024 6 -$252,078 4 Director 12 Mar 2024, 18:47
ALKS Alkermes plc. 26 Feb 2024 12 +$2,181,715 4 Director and CEO, Alkermes plc, Director 27 Feb 2024, 16:02
NBIX NEUROCRINE BIOSCIENCES INC 20 Feb 2024 3 -$1,987,047 4 Director 22 Feb 2024, 17:11
ALKS Alkermes plc. 08 Feb 2024 2 -$2,456,335 4 Director and CEO, Alkermes plc, Director 12 Feb 2024, 22:00
NBIX NEUROCRINE BIOSCIENCES INC 17 May 2023 1 $0 4 Director 19 May 2023, 17:20
ALKS Alkermes plc. 23 Feb 2023 1 $0 4 Director and CEO, Alkermes plc, Director 24 Feb 2023, 19:26
ALKS Alkermes plc. 20 Feb 2023 5 -$1,891,279 4 Director and CEO, Alkermes plc, Director 22 Feb 2023, 16:00
NBIX NEUROCRINE BIOSCIENCES INC 03 Jan 2023 3 -$1,788,045 4 Director 05 Jan 2023, 17:18
NBIX NEUROCRINE BIOSCIENCES INC 18 May 2022 1 $0 4 Director 20 May 2022, 16:11
NBIX NEUROCRINE BIOSCIENCES INC 09 May 2022 6 -$1,144,462 4 Director 11 May 2022, 17:36
ALKS Alkermes plc. 05 May 2022 7 -$2,270,284 4 Director and CEO, Alkermes plc, Director 06 May 2022, 17:04
ALKS Alkermes plc. 18 Feb 2022 4 -$360,801 4 Director and CEO, Alkermes plc, Director 23 Feb 2022, 15:37
ALKS Alkermes plc. 16 Feb 2022 3 -$215,338 4 Director and CEO, Alkermes plc, Director 17 Feb 2022, 15:21
ALKS Alkermes plc. 14 Sep 2021 2 -$1,109,770 4 Director and CEO, Alkermes plc, Director 16 Sep 2021, 16:32
NBIX NEUROCRINE BIOSCIENCES INC 19 May 2021 1 $0 4 Director 20 May 2021, 16:09
ALKS Alkermes plc. 18 May 2021 3 -$569,655 4 Director and CEO, Alkermes plc, Director 19 May 2021, 16:27
ALKS Alkermes plc. 11 May 2021 4 -$597,589 4 Director and CEO, Alkermes plc, Director 12 May 2021, 16:24
ALKS Alkermes plc. 06 May 2021 3 -$368,910 4 Director and CEO, Alkermes plc, Director 07 May 2021, 16:47